Cash, cash equivalents, and short-term marketable securities (Tables)

3 Months Ended

Mar. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Restricted Cash

The following table summarizes the Company's cash, cash equivalents, and restricted cash as of March 31, 2024 and 2023.

	Three Months Ended March 31, 2024				Three Months Ended March 31, 2023
(in thousands)	Beginning of period		End of period		Beginning of period		End of period
Cash and cash equivalents	$	174,561	$	75,186	$	128,885	$	122,825
Restricted cash included in other assets, noncurrent	478		478		478		478
Total cash, cash equivalents and restricted cash per statement of cash flows	$	175,039	$	75,664	$	129,363	$	123,303

Schedule of Debt Securities, Available-for-Sale

The following tables summarize the Company's marketable securities held at March 31, 2024 and December 31, 2023.

	March 31, 2024
(in thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities
U.S. treasury securities	$	108,050	$	—	$	(90)	$	107,960

	December 31, 2023
(in thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities
U.S. treasury securities	$	29,535	$	13	$	—	$	29,548
U.S. government agency securities	4,977		—		(2)		4,975
Total	$	34,512	$	13	$	(2)	$	34,523